authors
- Rusthoven, James
- Eisenhauer, E
- Butts, C
- Gregg, R
- Dancey, J
- Fisher, B
- Iglesias, J
Phase II trial of the multi-targeted antifolate LY231514 (MTA) as first-line therapy for patients with advanced non-small cell lung cancer (NSCLC)
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- September 1, 1997
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- 1117 Public Health and Health Services (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- European Journal of Cancer Journal